Avant Brands Targets German Cannabis Market Through IMC Partnership

Avant Brands Inc., a leading producer of premium cannabis, and IM Cannabis Corp., a top medical cannabis company, announced an International Trademark Licensing Agreement to launch Avant's BLK MKT™ brand in the German cannabis market. This partnership grants Adjupharm GmbH, IMC's German subsidiary, exclusive rights to debut the BLK MKT™ brand in Germany, marking a significant milestone in the relationship between the two companies.

Norton Singhavon, Avant's CEO, expressed excitement over the agreement, emphasizing its strategic importance for global expansion in the ultra-premium cannabis sector. The collaboration, leveraging Avant's high-quality cannabis production and IMC's sales expertise, is poised to meet the demand in the burgeoning German medical cannabis market.

The agreement arrives at a pivotal time following recent legalization changes in Germany, indicating a progressive shift in the country's drug policy and a growing recognition of cannabis' therapeutic benefits. Avant and IMC are optimistic about their combined efforts to successfully position the BLK MKT brand in Germany.

Avant's commitment to quality is highlighted by its cultivation facilities' certifications, positioning the company well for domestic and international market demands. Adjupharm, being a leading distributor in Germany, views this partnership as an opportunity to further strengthen its market position.